Logo image of ERO

ERO COPPER CORP (ERO) Stock Fundamental Analysis

NYSE:ERO - New York Stock Exchange, Inc. - CA2960061091 - Common Stock - Currency: USD

16.77  -0.48 (-2.78%)

After market: 16.52 -0.25 (-1.49%)

Fundamental Rating

5

Taking everything into account, ERO scores 5 out of 10 in our fundamental rating. ERO was compared to 156 industry peers in the Metals & Mining industry. ERO has an excellent profitability rating, but there are concerns on its financial health. ERO is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

In the past year ERO was profitable.
ERO had a positive operating cash flow in the past year.
Of the past 5 years ERO 4 years were profitable.
ERO had a positive operating cash flow in each of the past 5 years.
ERO Yearly Net Income VS EBIT VS OCF VS FCFERO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.12%, ERO is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
ERO has a Return On Equity of 2.65%. This is in the better half of the industry: ERO outperforms 62.82% of its industry peers.
ERO has a better Return On Invested Capital (8.65%) than 80.13% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ERO is below the industry average of 10.97%.
The last Return On Invested Capital (8.65%) for ERO is above the 3 year average (8.14%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.12%
ROE 2.65%
ROIC 8.65%
ROA(3y)3.34%
ROA(5y)9.91%
ROE(3y)6.26%
ROE(5y)18.84%
ROIC(3y)8.14%
ROIC(5y)19.2%
ERO Yearly ROA, ROE, ROICERO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

Looking at the Profit Margin, with a value of 3.86%, ERO is in the better half of the industry, outperforming 68.59% of the companies in the same industry.
ERO has a Operating Margin of 30.81%. This is amongst the best in the industry. ERO outperforms 86.54% of its industry peers.
ERO's Operating Margin has been stable in the last couple of years.
ERO's Gross Margin of 41.85% is amongst the best of the industry. ERO outperforms 83.33% of its industry peers.
ERO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 30.81%
PM (TTM) 3.86%
GM 41.85%
OM growth 3Y-22.63%
OM growth 5Y-1.37%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.13%
GM growth 5Y-1.36%
ERO Yearly Profit, Operating, Gross MarginsERO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ERO is creating some value.
ERO has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ERO has more shares outstanding
Compared to 1 year ago, ERO has a worse debt to assets ratio.
ERO Yearly Shares OutstandingERO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ERO Yearly Total Debt VS Total AssetsERO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

ERO has an Altman-Z score of 2.13. This is not the best score and indicates that ERO is in the grey zone with still only limited risk for bankruptcy at the moment.
ERO has a Altman-Z score (2.13) which is in line with its industry peers.
A Debt/Equity ratio of 0.84 indicates that ERO is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.84, ERO is not doing good in the industry: 85.90% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF N/A
Altman-Z 2.13
ROIC/WACC1.07
WACC8.11%
ERO Yearly LT Debt VS Equity VS FCFERO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 1.05 indicates that ERO should not have too much problems paying its short term obligations.
ERO has a worse Current ratio (1.05) than 83.97% of its industry peers.
A Quick Ratio of 0.78 indicates that ERO may have some problems paying its short term obligations.
ERO's Quick ratio of 0.78 is on the low side compared to the rest of the industry. ERO is outperformed by 78.21% of its industry peers.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 0.78
ERO Yearly Current Assets VS Current LiabilitesERO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

7

3. Growth

3.1 Past

ERO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.78%, which is quite impressive.
The Earnings Per Share has been decreasing by -2.60% on average over the past years.
The Revenue has grown by 13.24% in the past year. This is quite good.
The Revenue has been growing by 10.55% on average over the past years. This is quite good.
EPS 1Y (TTM)22.78%
EPS 3Y-30.56%
EPS 5Y-2.6%
EPS Q2Q%118.75%
Revenue 1Y (TTM)13.24%
Revenue growth 3Y-1.36%
Revenue growth 5Y10.55%
Sales Q2Q%18.24%

3.2 Future

Based on estimates for the next years, ERO will show a very strong growth in Earnings Per Share. The EPS will grow by 46.14% on average per year.
ERO is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.76% yearly.
EPS Next Y175.88%
EPS Next 2Y97.55%
EPS Next 3Y64.71%
EPS Next 5Y46.14%
Revenue Next Year66.59%
Revenue Next 2Y41.49%
Revenue Next 3Y27.6%
Revenue Next 5Y19.76%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ERO Yearly Revenue VS EstimatesERO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
ERO Yearly EPS VS EstimatesERO Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2 3

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

ERO is valuated rather expensively with a Price/Earnings ratio of 17.29.
Compared to the rest of the industry, the Price/Earnings ratio of ERO indicates a somewhat cheap valuation: ERO is cheaper than 79.49% of the companies listed in the same industry.
ERO is valuated rather cheaply when we compare the Price/Earnings ratio to 26.92, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 5.51 indicates a rather cheap valuation of ERO.
92.95% of the companies in the same industry are more expensive than ERO, based on the Price/Forward Earnings ratio.
ERO's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.49.
Industry RankSector Rank
PE 17.29
Fwd PE 5.51
ERO Price Earnings VS Forward Price EarningsERO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ERO is valued a bit cheaper than the industry average as 69.23% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.94
ERO Per share dataERO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of ERO may justify a higher PE ratio.
ERO's earnings are expected to grow with 64.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.1
PEG (5Y)N/A
EPS Next 2Y97.55%
EPS Next 3Y64.71%

More info and screens

0

5. Dividend

5.1 Amount

ERO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ERO COPPER CORP

NYSE:ERO (6/27/2025, 8:04:39 PM)

After market: 16.52 -0.25 (-1.49%)

16.77

-0.48 (-2.78%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-05 2025-05-05/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners72.53%
Inst Owner Change-1.45%
Ins Owners6.17%
Ins Owner ChangeN/A
Market Cap1.74B
Analysts82.22
Price Target19.17 (14.31%)
Short Float %4.34%
Short Ratio7.98
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)15.68%
Min EPS beat(2)-44.95%
Max EPS beat(2)76.3%
EPS beat(4)2
Avg EPS beat(4)6.21%
Min EPS beat(4)-44.95%
Max EPS beat(4)76.3%
EPS beat(8)3
Avg EPS beat(8)4.95%
EPS beat(12)4
Avg EPS beat(12)-7.23%
EPS beat(16)6
Avg EPS beat(16)-5.64%
Revenue beat(2)0
Avg Revenue beat(2)-10.51%
Min Revenue beat(2)-17.25%
Max Revenue beat(2)-3.77%
Revenue beat(4)0
Avg Revenue beat(4)-11.26%
Min Revenue beat(4)-20.39%
Max Revenue beat(4)-3.62%
Revenue beat(8)1
Avg Revenue beat(8)-7.62%
Revenue beat(12)3
Avg Revenue beat(12)-7.35%
Revenue beat(16)6
Avg Revenue beat(16)-3.91%
PT rev (1m)6.83%
PT rev (3m)2.91%
EPS NQ rev (1m)0%
EPS NQ rev (3m)10.22%
EPS NY rev (1m)0%
EPS NY rev (3m)4.27%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.42%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.23%
Valuation
Industry RankSector Rank
PE 17.29
Fwd PE 5.51
P/S 3.55
P/FCF N/A
P/OCF 8.97
P/B 2.43
P/tB 2.43
EV/EBITDA 9.94
EPS(TTM)0.97
EY5.78%
EPS(NY)3.04
Fwd EY18.15%
FCF(TTM)-0.92
FCFYN/A
OCF(TTM)1.87
OCFY11.15%
SpS4.73
BVpS6.89
TBVpS6.89
PEG (NY)0.1
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.12%
ROE 2.65%
ROCE 10.31%
ROIC 8.65%
ROICexc 9.15%
ROICexgc 9.15%
OM 30.81%
PM (TTM) 3.86%
GM 41.85%
FCFM N/A
ROA(3y)3.34%
ROA(5y)9.91%
ROE(3y)6.26%
ROE(5y)18.84%
ROIC(3y)8.14%
ROIC(5y)19.2%
ROICexc(3y)9.9%
ROICexc(5y)23.79%
ROICexgc(3y)9.9%
ROICexgc(5y)23.79%
ROCE(3y)9.69%
ROCE(5y)22.87%
ROICexcg growth 3Y-45.44%
ROICexcg growth 5Y-14.21%
ROICexc growth 3Y-45.44%
ROICexc growth 5Y-14.21%
OM growth 3Y-22.63%
OM growth 5Y-1.37%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.13%
GM growth 5Y-1.36%
F-Score6
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF N/A
Debt/EBITDA 2.56
Cap/Depr 349.72%
Cap/Sales 59.1%
Interest Coverage 4.22
Cash Conversion 82.9%
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 0.78
Altman-Z 2.13
F-Score6
WACC8.11%
ROIC/WACC1.07
Cap/Depr(3y)480.9%
Cap/Depr(5y)425.39%
Cap/Sales(3y)82.97%
Cap/Sales(5y)64.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.78%
EPS 3Y-30.56%
EPS 5Y-2.6%
EPS Q2Q%118.75%
EPS Next Y175.88%
EPS Next 2Y97.55%
EPS Next 3Y64.71%
EPS Next 5Y46.14%
Revenue 1Y (TTM)13.24%
Revenue growth 3Y-1.36%
Revenue growth 5Y10.55%
Sales Q2Q%18.24%
Revenue Next Year66.59%
Revenue Next 2Y41.49%
Revenue Next 3Y27.6%
Revenue Next 5Y19.76%
EBIT growth 1Y76.53%
EBIT growth 3Y-23.68%
EBIT growth 5Y9.03%
EBIT Next Year216.04%
EBIT Next 3Y61.79%
EBIT Next 5Y45.5%
FCF growth 1Y54.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y67.22%
OCF growth 3Y-26.39%
OCF growth 5Y2.62%